Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totaling 8,583 shares, an increase of 104.6% from the May 31st total of 4,196 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 28,647 shares, the short-interest ratio is currently 0.3 days.
Nihon Kohden Price Performance
Shares of OTCMKTS:NHNKY remained flat at $8.76 during midday trading on Tuesday. 3,564 shares of the company were exchanged, compared to its average volume of 27,984. The stock has a market cap of $1.47 billion, a PE ratio of 14.84 and a beta of 0.40. The company’s 50 day simple moving average is $9.01 and its two-hundred day simple moving average is $10.05. Nihon Kohden has a fifty-two week low of $8.12 and a fifty-two week high of $14.21.
Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The firm had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. As a group, equities analysts anticipate that Nihon Kohden will post 0.6 earnings per share for the current year.
Analyst Ratings Changes
Read Our Latest Research Report on NHNKY
Nihon Kohden Company Profile
Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.
The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.
Featured Articles
- Five stocks we like better than Nihon Kohden
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
- These 3 Dividend Stocks Could Boost Your Income This July
- Rocket Lab Defies Gravity With $8B Buyout
- Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
